A Survey of Breast Cancer Patients With Metastatic Bone Disease Receiving Oral Ibandronate
Status: COMPLETED
Study type: OBSERVATIONAL
Conditions: Metastatic Breast Cancer
Sponsor: Hoffmann-La Roche